Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03926208 · ClinicalTrials.gov registry record · NA

Dilute Betadine Soak and Scrub for Foot and Ankle Surgery

A NA study of Postoperative Complications and Postoperative Infection, sponsored by Rush University Medical Center.

Completed
Registry status
NA
Development phase
242
Enrollment target
1
Study location

NCT03926208: Completed NA study of Postoperative Complications and Postoperative Infection, sponsored by Rush University Medical Center.

NCT03926208 is a NA study of Postoperative Complications and Postoperative Infection that has completed, run by Rush University Medical Center. The registered enrollment target is 242 participants, below the 550-participant average among 20 other Postoperative Complications trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03926208, a NA study of Postoperative Complications and Postoperative Infection, has completed, sponsored by Rush University Medical Center.

COMPLETED
Registry status
NA
Development phase
242 participants
Enrollment target
1
Study location

Study Summary

Infection and wound complications are the most common complications following orthopaedic foot and ankle procedures, and the infection rate following these procedures is higher than in procedures involving other areas of the body.The purpose of this randomized controlled trial is to determine whether a standard chlorhexidine prep can be augmented with a soak \& scrub of the foot in dilute betadine to reduce the rate of positive cultures from the hallux nail fold prior to surgery.

Primary Outcome

Cotton swab of hallux nail fold. Culture of any microorganisms found. The results indicate the number of patients with positive bacterial culture growth.

Interventions

  • PROCEDURE Soak and Scrub
  • PROCEDURE Clorhexadine scrub

Study Locations (1)

Illinois

  • Rush University Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 242 participants
Start Date 2019-05-24
Est. Completion 2020-01-01
Phase NA
Rush University Medical Center

320 total trials

What the finished NCT03926208 record still lists

NCT03926208 is an interventional study that assigns participants to a tested intervention. The registered 242 participants enrollment target is mid-sized for trials with a published cap, below the 550-participant average among 20 other Postoperative Complications trials with a reported enrollment target (56% lower).

The record links to 2 conditions, with Postoperative Complications appearing as the primary indexed condition, and to 2 interventions - of which Soak and Scrub is the first listed.

NCT03926208 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT03926208 about?

NCT03926208 is a clinical study titled "Dilute Betadine Soak and Scrub for Foot and Ankle Surgery". Infection and wound complications are the most common complications following orthopaedic foot and ankle procedures, and the infection rate following these procedures is higher than in procedures involving other areas of the body.The purpose of this randomized controlled trial is to determine whethe...

What is the current status of trial NCT03926208?

This trial is currently completed. It is a NA study. The enrollment target is 242 participants. The study started on 2019-05-24. Estimated completion is 2020-01-01.

What conditions does trial NCT03926208 study?

This clinical trial studies the following conditions: Postoperative Complications, Postoperative Infection.

What interventions are being tested in trial NCT03926208?

The interventions under investigation include: Soak and Scrub (PROCEDURE), Clorhexadine scrub (PROCEDURE).

Who is sponsoring clinical trial NCT03926208?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03926208 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Complications

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03926208's enrollment target sits among peer trials

242 6th of 20 higher than 15 of 20 other Postoperative Complications trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Postoperative Complications trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03556228 · 242 participants · Phase 1

    VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • NCT04260022 · 242 participants · Phase 1

    Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

  • NCT04459000 · 242 participants · NA

    Substance Use Treatment and Access to Resources (STARS) Project

  • NCT05644496 · 242 participants · Phase 4

    ZYNRELEF for Pain Management in Total Knee Arthroplasty

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03926208, the US trial registry maintained by the National Library of Medicine. NCT03926208 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.